Understanding FLT3 in AML: What It Means and How It’s Treated

Event Description
Join us for a special session focused on FLT3 mutations in Acute Myeloid Leukemia (AML), one of the most common genetic changes found in AML patients. Dr. Nicholas Short from MD Anderson Cancer Center will explain what FLT3 mutations are, how they affect treatment decisions, and what targeted therapies are available today. Whether you’re newly diagnosed or navigating ongoing treatment, this session will help you understand the role FLT3 plays in your AML journey and what questions to ask your doctor.
Schedule & Agenda

Marilu introduces the agenda for the event and featured speaker Dr. Nicholas Short

Marilu introduces the agenda for the event and featured speaker Dr. Nicholas Short

Dr. Short talks about FLT3 mutations in AML

Dr. Short talks about FLT3 mutations in AML

Type your questions in the chat and we will answer them!

Type your questions in the chat and we will answer them!
Speakers & Moderators

Marilu is an International Medical Graduate passionate about supporting patients and building strong community connections. Since joining HealthTree, she has contributed in roles such as Myeloma Navigator and Patient Navigator, always focused on empowering patients. Now, as Event Operations Manager, she organizes webinars featuring key speakers to address topics relevant to AML and MDS patients and their families. Beyond her work, Marilu is a travel enthusiast and a good listener who enjoys spending time with her family and friends.

Dr. Nicholas Short is an Associate Professor in the Department of Leukemia at The University of Texas MD Anderson Cancer Center. He specializes in adult acute leukemias, with a focus on targeted therapies and measurable residual disease (MRD). Dr. Short leads numerous phase I and II clinical trials exploring new treatment options for AML and ALL. He has authored over 200 peer-reviewed publications and has presented his research at major conferences like ASH and ASCO. His work has earned him prestigious honors, including the ASCO Young Investigator Award and the ASH Junior Faculty Scholar Award.
Join the Conversation
This event is part of the Lab Values and Testing group in HealthTree Connect, a social media platform for people with blood cancer. If you want to connect with other patients and caregivers and talk about this topic, join HealthTree Connect.
Have Any Questions?
Thank you for your interest in the event. If you have any questions, we would love to help!
Feel free to give us a call or send us a message below.
Get In Touch With Us
1-800-709-1113
Support@healthtree.org


Get the Latest Multiple Myeloma Updates, Delivered to You.
By subscribing to the HealthTree newsletter, you'll receive the latest research, treatment updates, and expert insights to help you navigate your health.